1346569-77-4

Upstream product

• 156-38-7 4-hydroxyphenylacetate 
• 108-24-7 acetic anhydride 
• 104-88-1 4-chlorobenzaldehyde 

Downstream Products

• 1346569-78-5 ethyl 3-(4-chlorophenyl)-2-(4-hydroxyphenyl)prop-2-enoate 
• 1346569-80-9 2-[4-(1,3-benzothiazol-2-ylmethoxy)phenyl]-3-(4-chlorophenyl)prop-2-enoic acid 
• 1346569-81-0 ethyl 2-[4-(1,3-benzothiazol-2-ylmethoxy)phenyl]-3-(4-chlorophenyl)prop-2-enoate 
• 1346569-76-3 3-(4-chlorophenyl)-2-[4-(imidazo[1,2-a]pyridin-2-ylmethoxy)phenyl]prop-2-enoic acid 
• 1346569-79-6 ethyl 3-(4-chlorophenyl)-2-[4-(imidazo[1,2-a]pyridin-2-ylmethoxy)phenyl]prop-2-enoate 
• 1346569-40-1 2-({4-[2-(4-chlorophenyl)-1-(5-methyl-4H-1,2,4-triazol-3-yl)ethenyl]phenoxy}methyl)imidazo[1,2-a]pyridine 
• 1346568-97-5 5-({4-[2-(4-chlorophenyl)-1-(1,3,4-oxadiazol-2-yl)ethenyl]phenoxy}methyl)-1H-indazole 
• 1346570-88-4 tert-butyl 5-({4-[2-(4-chlorophenyl)-1-(1,3,4-oxadiazol-2-yl)ethenyl]phenoxy}methyl)-1H-indazole-1-carboxylate 
• 1346568-95-3 5-({4-[2-(4-chlorophenyl)-1-(1,3,4-oxadiazol-2-yl)ethenyl]phenoxy}methyl)-1H-pyrrolo[3,2-b]pyridine 
• 1346570-87-3 5-({4-[2-(4-chlorophenyl)-1-(1,3,4-oxadiazol-2-yl)ethenyl]phenoxy}methyl)-1-[(4-methylphenyl)sulfonyl]-1H-pyrrolo[3,2-b]pyridine 
• 1346568-89-5 2-({4-[2-(4-chlorophenyl)-1-(1,3,4-oxadiazol-2-yl)vinyl]phenoxy}methyl)imidazo[1,2-a]pyridine 
• 1346567-72-3 3-(4-chlorophenyl)-2-[4-(imidazo[1,2-a]pyridin-2-ylmethoxy)phenyl]-N-methyl-prop-2-enamide 
• 1346570-36-2 3-(4-chlorophenyl)-2-[4-(imidazo[1,2-a]pyridin-2-ylmethoxy)phenyl]prop-2-enehydrazide 
• 1346570-32-8 4-[2-(4-chlorophenyl)-1-(1,3,4-oxadiazol-2-yl)ethenyl]phenol 

Relevant academic research and scientific papers

ARYL SUBSTITUTED OLEFINIC COMPOUNDS AS PDE10A INHIBITORS

The present invention provides aryl substituted olefinic compounds as Phosphodiesterase 1 0A (PDE 1 0A) inhibitors. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders by inhibiting Phospho